Searched for
2DG DRUG
DRDO to get 2 per cent royalty from Dr Reddy's on sale of anti-Covid drug 2-DG in India: GovtThe Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...- BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DGLast month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild t...
- MSN Labs enters into licence agreement with DRDE for COVID-19 drug 2-DGDeveloped by DRDO, 2-DG has been granted permission by the Drug Controller General of India (DCGI) for emergency use as adjunct therapy in ...
- Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institu...
- Laurus Labs receives licence from DRDO to manufacture and market COVID drug 2DG2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus L...
- IICT ties up with Nosch Labs for transfer of process knowhow to make anti-Covid drug 2-DGA press release here on Monday said as per the pact signed on June 11, Nosch Labs would commence manufacture of 2-DG drug after obtaining r...
- Dr. Reddy's Laboratories announces commercial launch of COVID-19 drug 2-DGIn the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand covera...
- Dr Reddy's announces commercial launch of COVID-19 drug 2-DGIn the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand covera...
- CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DGThe CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement ...
- DRDO invites EoI to transfer technology of 2-DG drug for bulk productionAccording to the EoI document, applications should be submitted before June 17 through email. "The EoI submitted by industries will be scru...
- DRDO calls for EoI to transfer 2DG with more playersDisclosing this on Tuesday evening, the DRDO chairman Dr G Satheesh Reddy said the EoIs were called from the interested Indian pharmaceutic...
- DRDO issues directions on usage of anti-COVID drug 2-DGThe Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...
- DRDO's antiviral drug 2-DG unlikely to get quick nod for Covid treatmentExperts said the 2-DG drug had earlier been considered for treatment of influenza, way back in 1959, and subsequently for other infectious ...
- Government mulling roping in 3-4 more firms to ramp up DRDO COVID-19 drug production2-DG has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS), in collaboration with Dr Reddy's Laboratories,...
- Dr Reddy’s warns public on spurious versions of 2DG, its anti-Covid drug, in the market“2DG is an oral antiviral drug that can be administered only upon prescription to hospitalized moderate to severe Covid-19 patients as adju...
- DRDO-Dr Reddy’s anti-Covid drug handed over to AIIMS, likely to cut O2 dependencyThe first batch of an Indian developed drug for Covid-19 patients that promises to reduce hospital stay and oxygen dependency was officiall...
- Rajnath Singh, Harsh Vardhan release first batch of DRDO's anti-COVID drug 2-DGThe Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...
- Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients todayThe first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation o...
- DRDO developed 2-DG drug could be game-changer: Karnataka Health Minister Dr K SudhakarThe 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine...
- DCGI approves anti-COVID drug developed by DRDO for emergency useAccording to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D...
Load More
